Intact Vascular, an Innovasc company, Secures $38.9 Million in Series B Financing to Accelerate Development of Endiovascular Dissection Repair Technology

The latest round, one of the largest private medical technology financings of 2015, was led by New Enterprise Associates (NEA) with participation from Quaker Partners and H.I.G. Bioventures.

Click here to read more at intactvascular.com.

About Sennet Capital

Leave a Reply

Your email address will not be published. Required fields are marked *